Healthcare

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

United States · United States Congress · 23 December 2019

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Affordable Drug Manufacturing Act of 2019

United States · United States Congress · 19 December 2019

Affordable Drug Manufacturing Act of 2019 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.

Conditional Approval Act

United States · United States Congress · 19 December 2019

Conditional Approval Act This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.

Parental Accessibility Rights for Emergency and Negligent Treatment Act

United States · United States Congress · 19 December 2019

Parental Accessibility Rights for Emergency and Negligent Treatment Act This bill expands the scope of advance directive policies and related disclosures for providers under Medicaid and the Children's Health Insurance Program (CHIP). Specifically, providers (e.g., hospitals, hospice programs, and home health care providers) must have advance directive policies for minors (rather than only adults) and must disclose such policies on the provider's website and upon request. Providers must also disclose information regarding (1) an individual's rights with respect to life-sustaining procedures, including hydration and sustenance; and (2) whether parental consent is required to provide, withdraw, or deny life-sustaining procedures, or to institute a do-not-resuscitate order, for a minor.

Parental Right to Know Act

United States · United States Congress · 19 December 2019

Parental Right to Know Act This bill expands the scope of advance directive policies and related disclosures for providers under Medicaid and the Children's Health Insurance Program (CHIP). Specifically, providers (e.g., hospitals, hospice programs, and home health care providers) must have advance directive policies for minors (rather than only adults). Providers must also disclose policies regarding parental access to a minor's medical records.

Conditional Approval Act

United States · United States Congress · 19 December 2019

Conditional Approval Act This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.

Lower Costs, More Cures Act of 2019

United States · United States Congress · 19 December 2019

Lower Costs, More Cures Act of 2019 This bill establishes and modifies several requirements to address prescription drug prices under Medicare. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, and establishes several reporting requirements for drug manufacturers with respect to drug prices.

A bill to amend the Internal Revenue Code of 1986 to allow for contributions to the Alzheimer's Research and Caregiving Trust Fund, and for other purposes.

United States · United States Congress · 19 December 2019

This bill establishes the Alzheimer's Research and Caregiving Trust Fund to pay for research regarding the treatment or cure of Alzheimer's disease and for education, counseling, respite, and other supportive services for individuals with Alzheimer's disease and their families, caregivers, and health care professionals. The bill allows taxpayers an election to contribute a whole dollar amount to the trust fund when they file their tax returns.

Ending the Diagnostic Odyssey Act of 2019

United States · United States Congress · 19 December 2019

Ending the Diagnostic Odyssey Act of 2019 This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Personalized Care Act of 2019

United States · United States Congress · 19 December 2019

Personalized Care Act of 2019 This bill revises provisions relating to health savings accounts (HSAs), including to redefine eligible individual for HSA purposes to allow increased participation in HSAs, increase the limit on contributions to HSAs, permit the payment of health insurance premiums from HSAs, include within the definition of qualified medical expenses periodic fees paid for medical services and amounts paid by a member of a health care sharing ministry, treat periodic provider fees as deductible medical expenses, allow payment of over-the-counter medicines or drugs from HSAs, and lower the 20% penalty for nonqualified distributions from HSAs to 10%. .

A resolution designating January 2020 as "National One Health Awareness Month" to promote awareness of organizations focused on public health, animal health, and environmental health collaboration throughout the United States and to recognize the critical contributions of those organizations to the future of the United States.

United States · United States Congress · 19 December 2019

This resolution designates January 2020 as National One Health Awareness Month and recognizes the importance of the One Health approach to protecting the health of people, animals, plants, and the environment. One Health is a collaborative, transdisciplinary approach with the goal of achieving optimal health outcomes recognizing the interconnection between people, animals, plants, and their shared environment.

Ally’s Act

United States · United States Congress · 18 December 2019

Ally's Act This bill requires private health insurance plans to cover certain hearing devices and systems (e.g., bone-anchored auditory implants) and related items and services. The bill also imposes limits on cost sharing.

PREVENT Act of 2020

United States · United States Congress · 18 December 2019

Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020 or the PREVENT Act of 2020 This bill requires the Centers for Disease Control and Prevention to establish a grant program to prevent the use of electronic nicotine delivery systems (e.g., e-cigarettes) among students in middle and high schools. To support the program, the Food and Drug Administration must collect user fees from manufacturers and importers of electronic nicotine delivery systems.

ALS Placebo No More Act

United States · United States Congress · 18 December 2019

ALS Placebo No More Act This bill requires the Food and Drug Administration and the National Institutes of Health to collaborate to provide all patients with ALS (amyotrophic lateral sclerosis, also referred to as Lou Gehrig's disease) with access to medicines in clinical trials.

To protect Americans with pre-existing conditions.

United States · United States Congress · 18 December 2019

This bill specifies that no American may be denied health insurance due to preexisting conditions. (Current law also prohibits such denials.)

EASE Behavioral Health Services Act

United States · United States Congress · 18 December 2019

Enhance Access to Support Essential Behavioral Health Services Act or the EASE Behavioral Health Services Act This bill removes restrictions that require the originating site (i.e., the location of the beneficiary) to be in a rural area, and allows the home of a beneficiary to serve as the originating site, for behavioral health telehealth services under Medicare. The bill also expands the scope of required guidance, studies, and reports to address the provision of such services under Medicaid.

Rural Hospital Closure Relief Act of 2019

United States · United States Congress · 18 December 2019

Rural Hospital Closure Relief Act of 2019 This bill allows additional hospitals to qualify as critical access hospitals (CAHs) that receive special payment under Medicare. Currently, in order to qualify as a CAH under Medicare, a hospital must either (1) be located more than 35 miles (or 15 miles in mountainous regions or areas with only secondary roads) from another hospital, or (2) have been certified prior to January 1, 2006, by the state as a necessary provider of services in the area. The bill allows a hospital to also qualify if the hospital is a small, rural hospital that (1) serves a health professional shortage area, or a high number of low-income individuals or Medicare or Medicaid beneficiaries; (2) has experienced financial losses for two consecutive years; and (3) attests to having a strategic plan to address financial solvency.

Rural Hospital Closure Relief Act of 2019

United States · United States Congress · 18 December 2019

Rural Hospital Closure Relief Act of 2019 This bill allows additional hospitals to qualify as critical access hospitals (CAHs) that receive special payment under Medicare. Currently, in order to qualify as a CAH under Medicare, a hospital must either (1) be located more than 35 miles (or 15 miles in mountainous regions or areas with only secondary roads) from another hospital, or (2) have been certified prior to January 1, 2006, by the state as a necessary provider of services in the area. The bill allows a hospital to also qualify if the hospital is a small, rural hospital that (1) serves a health professional shortage area, or a high number of low-income individuals or Medicare or Medicaid beneficiaries; (2) has experienced financial losses for two consecutive years; and (3) attests to having a strategic plan to address financial solvency.

PREVENT Act of 2020

United States · United States Congress · 18 December 2019

Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020 (or the PREVENT Act of 2020) This bill requires the Centers for Disease Control and Prevention to establish a grant program to prevent the use of electronic nicotine delivery systems (e.g., e-cigarettes) among students in middle and high schools. To support the program, the Food and Drug Administration must collect user fees from manufacturers and importers of electronic nicotine delivery systems.

Expanding Access to Low-Cost Generics Act of 2019

United States · United States Congress · 18 December 2019

Expanding Access to Low-Cost Generics Act of 2019 This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.

Ambulatory Surgical Center Quality and Access Act of 2019

United States · United States Congress · 18 December 2019

Ambulatory Surgical Center Quality and Access Act of 2019 This bill establishes and modifies certain requirements relating to Medicare payments for ambulatory surgical center (ASC) services. Specifically, the bill (1) requires the payment system for ASC services to feature certain positive annual adjustments equivalent to those made with respect to hospital outpatient department (OPD) services; (2) revises quality reporting requirements to permit publicly available, side-by-side comparisons of quality measures for ASCs and OPDs in the same geographic area; and (3) requires the Centers for Medicare & Medicaid Services (CMS), when excluding requested procedures from the list of those approved to be performed in ASCs, to cite specified reasons for doing so. With respect to excluding procedures from the approved list for ASCs, the CMS may not cite as a basis for exclusion that a procedure can only be reported using an unlisted surgical procedure code. (Physicians sometimes use unlisted codes when performing new procedures or services if no existing code is adequately descriptive.)

Pursuing Equity in Mental Health Act

United States · United States Congress · 17 December 2019

Pursuing Equity in Mental Health Act of 2019 This bill establishes programs to support school-based mental health services and address racial and ethnic mental health disparities, among other provisions. Specifically, the Substance Abuse and Mental Health Services Administration (SAMHSA) must award grants for school- and community-based, mental health services. Such services must be trauma-informed and designed to provide comprehensive, culturally-appropriate interventions at a school-wide level. Further, the bill requires the SAMSHA to award grants that address racial and ethnic health disparities by (1) providing integrated health care in areas with a high proportion of racial and ethnic minority groups and (2) developing national programs for health professionals to reduce such disparities. The bill also (1) reauthorizes the minority fellowship program to support the education of mental health professionals who provide services to racial and ethnic minorities, (2) establishes a commission to research the effects of social media use on adolescents, and (3) prohibits the use of federal funds for specified conversion therapy in the context of sexual orientation or sexual identity.

Prevent Interruptions in Physical Therapy Act of 2019

United States · United States Congress · 17 December 2019

Prevent Interruptions in Physical Therapy Act of 2019 This bill allows a physical therapist to receive payment under Medicare for services provided to the physical therapist's patients by another physical therapist through a qualifying temporary arrangement, regardless of the geographic area or population served. Currently, physical therapists may only receive payment with respect to such arrangements for services provided in medically underserved, rural, or health professional shortage areas.

SAFE SEX Workers Study Act

United States · United States Congress · 17 December 2019

SESTA/FOSTA Examination of Secondary Effects for Sex Workers Study Act or the SAFE SEX Workers Study Act This bill requires the Department of Health and Human Services to study the impacts of the reduction in access to client-screening, information-sharing, and harm-reduction websites resulting from the Allow States and Victims to Fight Online Sex Trafficking Act of 2017 on individuals engaged in adult, consensual sex work. The study must utilize community-based nonprofits to conduct surveys and interviews of sex workers to collect information about (1) experiences of violence from clients; (2) interactions with law enforcement; (3) experiences with exploitation; and (4) the impact on housing stability and mental health, among other effects.

Lower Insulin Costs Now Act

United States · United States Congress · 17 December 2019

Lower Insulin Costs Now Act This bill requires the Food and Drug Administration (FDA) to continue to review applications for certain biological products under an earlier review process, notwithstanding recent FDA guidance. (A 2009 law established a new procedure for approving biological products but allowed certain products in an already approved product class to receive approval under the earlier procedure until March 23, 2020; subsequently, in December 2018, the FDA issued guidance stating that an application filed under the earlier procedure that is not approved by March, 23, 2020, will not be approved.) The bill requires the FDA to continue reviewing an application filed not later than March 23, 2019, under the earlier procedure, even if it was not approved as of March 23, 2020.  Such an application not approved after October 1, 2022, shall be deemed withdrawn. Such an approved application shall be deemed a biological product license.

AFIRM Act

United States · United States Congress · 17 December 2019

Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2019 or the AFIRM Act This bill makes a series of administrative and procedural changes to the Medicare appeals process, such as authorizing the creation of Medicare magistrates to handle smaller claims and allowing adjudicators to consolidate cases under certain circumstances.

Liver Illness Visibility, Education, and Research Act of 2019

United States · United States Congress · 17 December 2019

Liver Illness Visibility, Education, and Research Act of 2019 This bill expands and coordinates activities related to the research of liver cancer and liver disease, including causes, prevention, detection, and treatment. Specifically, the National Cancer Institute must establish an inter-institute working group to coordinate efforts to cure liver cancer and liver disease, including research into such cases resulting from hepatitis B, and may award grants to develop preventative and diagnostic measures as well as support for experimental treatment options. The bill further establishes grant programs, administered by the Centers for Disease Control and Prevention, to support liver disease prevention services, diagnostics, and hepatitis tracking programs and to raise awareness about liver disease within high-risk communities. The renamed National Institute of Diabetes and Digestive, Kidney, and Liver Diseases also must prioritize programs addressing liver disease, including (1) establishing a national clearinghouse for patient data and (2) developing or expanding the centers for research of liver disease.

SAVE Moms and Babies Act of 2019

United States · United States Congress · 17 December 2019

Support And Value Expectant Moms and Babies Act of 2019 or the SAVE Moms and Babies Act of 2019 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

NOPAIN Act

United States · United States Congress · 17 December 2019

Non-Opioids Prevent Addiction In the Nation Act or the NOPAIN Act This bill temporarily establishes separate payments for certain non-opioid treatments under the Medicare prospective payment system for hospital outpatient department services and the payment system for ambulatory surgical center services. The bill applies to pain management treatments that are able to replace or reduce opioid consumption, as shown through clinical trials or data.

FRAC Act of 2019

United States · United States Congress · 17 December 2019

Fracturing Responsibility and Awareness of Chemicals Act or the FRAC Act This bill revises requirements governing hydraulic fracturing operations under the Safe Drinking Water Act. Hydraulic fracturing or fracking is a process to extract underground resources such as oil or gas from a geologic formation by injecting water, a propping agent (e.g., sand), and chemical additives into a well under enough pressure to fracture the geological formation. The bill repeals the exemption for such operations relating to oil and natural gas production activities under the act. The bill allows the Environmental Protection Agency (EPA) to prescribe regulations that authorize a state to seek primary enforcement responsibility for hydraulic fracturing operations for oil and natural gas without seeking to assume primary enforcement responsibility for other types of underground injection control wells. The bill requires public disclosure of the chemicals used in hydraulic fracturing operations. The chemicals intended for use in underground injections must be disclosed before the operations commence. The chemicals actually used must be disclosed the end of the operations. In the event that the proprietary chemical formula of a chemical used in such hydraulic fracturing is necessary for medical diagnosis, treatment, or emergency response, hydraulic fracturing operations must disclose the formula or the specific chemical identity of a trade secret chemical to the state, the EPA, a first responder, or a health care practitioner upon request, regardless of the existence of a written statement of need or a confidentiality agreement.

Isaiah Baker and Margie Harris-Austin Act

United States · United States Congress · 16 December 2019

Isaiah Baker and Margie Harris-Austin Act This bill allows state Medicaid programs to cover certain home- and community-based services, self-directed personal assistance services, and home- and community-based attendant services that are provided in acute care hospitals. The bill specifies, among other criteria, that such services may not be duplicative of, or serve as a substitute for, necessary or obligatory hospital services.

Lowest Price for Patients Act

United States · United States Congress · 16 December 2019

Lowest Price for Patients Act This bill requires pharmacies to disclose to consumers when dispensing a prescription drug (1) the cost of the drug under the consumer's insurance plan, and (2) the cost of the drug without using their plan.

End Valley Fever Now Act

United States · United States Congress · 16 December 2019

End Valley Fever Now Act This bill provides various supports to address the occurrence of valley fever, which is an infection caused by the fungus Coccidioides that is commonly found in the southwestern United States as well as parts of Mexico, Central America, and South America.

Food Safety Modernization for Innovative Technologies Act

United States · United States Congress · 16 December 2019

Food Safety Modernization for Innovative Technologies Act This bill provides statutory authority for joint agency jurisdiction over food intended for humans that is produced using animal cell culture technology. The Food and Drug Administration (FDA) shall oversee tissue collection, cell lines, and cell banks. The FDA shall regulate food derived from cell lines of animals other than livestock or poultry, and the Department of Agriculture shall regulate food derived from cell lines of livestock and poultry.

Medical Education for a Diverse America Act

United States · United States Congress · 13 December 2019

Medical Education for a Diverse America Act This bill requires time spent by medical residents in certain cultural training to count towards a determination of a hospital's number of full-time equivalent residents for purposes of graduate medical education payments under Medicare.

SENIOR CARE Act

United States · United States Congress · 13 December 2019

Supporting and Empowering the Nation to Improve Outcomes that Reaffirm Careers, Activities, and Recreation for the Elderly Act or the SENIOR CARE Act This bill expands eligibility for the Medicaid Ticket to Work Program to include individuals who are 65 years of age or older. (Under the current program, states may establish a Medicaid buy-in option for working individuals with disabilities whose income exceeds the customary limits and who are between the ages of 16 and 64.)

Expanded Food Safety Investigation Act of 2019

United States · United States Congress · 12 December 2019

Expanded Food Safety Investigation Act of 2019 This bill provides that the Food and Drug Administration (FDA) may, under specified circumstances, request access to a concentrated animal-feeding operation (i.e., a stabled or confined animal-feeding operation) to conduct microbial sampling. Specifically, the bill allows the FDA to request access if the FDA determines that sampling is necessary to facilitate an investigation of a foodborne-illness outbreak, determine the cause of the outbreak, or address other public health needs. The bill provides that such an operation shall be subject to penalties for refusing such a sampling.

Increasing Access to Mental Health Act of 2019

United States · United States Congress · 12 December 2019

Increasing Access to Mental Health Act of 2019 This bill directs the Department of Health and Human Services to establish a Task Force on Local Mental Health Needs to assess, and report on, the impact of the exclusion of Medicaid coverage for services at mental health institutions with more than 16 beds. The bill also establishes a grant program to coordinate and deliver mental health services in certain qualified community entities.

Expressing the sense of the Congress that assisted suicide (sometimes referred to using other terms) puts everyone, including those most vulnerable, at risk of deadly harm.

United States · United States Congress · 12 December 2019

This concurrent resolution expresses the sense of Congress that the federal government should ensure that (1) every person facing the end of their life has access to quality, comprehensive medical care and (2) policies or practices supporting assisted suicide are not adopted.

LAB Act

United States · United States Congress · 12 December 2019

Laboratory Access for Beneficiaries Act or the LAB Act This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.

VHA CRED Act of 2019

United States · United States Congress · 12 December 2019

Veterans Health Administration Caregiver Retention and Eligibility Determination Act of 2019 or the VHA CRED Act of 2019 This bill requires the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) to prescribe regulations, administrative guidance, and management controls applicable to the credentialing of certain appointed health care positions. Under the bill, VHA personnel who verify credentials for appointees, review qualifications for such persons, or hire such persons must undergo periodic training to review relevant law and policy regarding provider qualifications for VHA employment. The bill requires the VHA to enroll health care appointees in continuous query of their record within the National Practitioner Data Bank. The VHA must also develop and implement a mechanism for monitoring the continuous query and updating information within the VA's credentialing system. At least once a year, the VHA must audit its appointed health care employees who have an adverse action reported on the National Practitioner Data Bank.

Territories Medicare Prescription Drug Assistance Equity Act of 2019

United States · United States Congress · 12 December 2019

Territories Medicare Prescription Drug Assistance Equity Act of 2019 This bill makes certain subsidies under the Medicare prescription drug benefit available to beneficiaries who reside in Puerto Rico or another U.S. territory. Current law makes such beneficiaries ineligible for premium and cost-sharing subsidies, but establishes a process for U.S. territories to apply for financial assistance with respect to the provision of Medicare prescription drugs. The bill eliminates this process and makes the subsidies available to beneficiaries who reside in a U.S. territory and are otherwise eligible.

National Biomedical Research Act

United States · United States Congress · 11 December 2019

National Biomedical Research Act This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups; and (5) other innovative research. The bill also requries annual reporting about the fund by the NIH, the FDA, and the Department of the Treasury.

Commemorating the centennial of Houston Methodist Hospital.

United States · United States Congress · 11 December 2019

This resolution commemorates the 100th anniversary of the Houston Methodist Hospital.

PACT Act of 2019

United States · United States Congress · 11 December 2019

Pediatricians Accelerate Childhood Therapies Act of 2019 or the PACT Act of 2019 This bill provides statutory authority for the Trans-National Institutes of Health (NIH) Pediatric Research Consortium to coordinate pediatric research across national health research institutions. The consortium, chaired by the director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, must develop priorities for the NIH to award research grants to early career pediatric researchers, including physician-scientists and researchers from underrepresented populations.

Gluten in Medicine Disclosure Act of 2019

United States · United States Congress · 11 December 2019

Gluten in Medicine Disclosure Act of 2019 This bill prohibits the sale of any drug intended for human use that contains an ingredient derived from a gluten-containing grain unless the drug's label (1) states that the drug contains such an ingredient, and (2) identifies the type of grain from which the ingredient is derived.

Real MEAT Act of 2019

United States · United States Congress · 11 December 2019

Real Marketing Edible Artificials Truthfully Act of 2019 or the Real MEAT Act of 2019 This bill prohibits the sale of any imitation meat food product unless its label includes (1) the word imitation , and (2) a statement that clearly indicates the product is not derived from or does not contain meat.

PROPOSALS TO ACHIEVE UNIVERSAL HEALTHCARE COVERAGE

United States · United States House of Representatives · 10 December 2019

Promoting Better Patient Data Security Act of 2019

United States · United States Congress · 10 December 2019

Promoting Better Patient Data Security Act of 2019 This bill addresses health information technology provisions concerning cybersecurity practices. Specifically, the Department of Health and Human Services may reduce fines and penalties for violations of certain federal privacy standards for health information if an entity subject to those standards has adopted particular cybersecurity practices.

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

United States · United States Congress · 10 December 2019

This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.